Mitral Valve Replacement in a Patient with Idiopathic Hypereosinophilic Syndrome and Pulmonary Arterial Hypertension

被引:8
作者
不详
机构
[1] Department of Cardiovascular Surgery, Suleyman Demirel University Medical School, Isparta
[2] Department of Anesthesiology, Suleyman Demirel University Medical School, Isparta
[3] Department of Cardiology, Suleyman Demirel University Medical School, Isparta
[4] Department of Internal Medicine, Suleyman Demirel University Medical School, Isparta
[5] Department of Pathology, Suleyman Demirel University Medical School, Isparta
[6] 32040, Isparta
关键词
THROMBOSIS;
D O I
10.1111/j.1540-8191.2008.00639.x
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Background and Aims: Idiopathic hypereosinophilic syndrome, a rarely seen systemic disease, may cause cardiac valvular lesions by eosinophilic infiltration. This report describes management of a 25-year-old woman with idiopathic hypereosinophilic syndrome, severe mitral stenosis, and pulmonary arterial hypertension. Methods: The patient was presented with haemoptysia and dyspnea on exertion. Echocardiography showed severe mitral stenosis and pulmonary arterial hypertension. Results: After hematological stabilization, she underwent mitral valve replacement using a No. 27 bovine pericardial valve. In the intensive care unit she had a pulmonary hypertensive crisis, which ameliorated gradually with sedation and nitroglycerin. She was extubated and discharged on the second and seventh days, respectively. Conclusion: Surgical experience for the patients with mitral dysfunction caused by idiopathic hypereosinophilic syndrome is limited. When mitral valve replacement is needed, the ideal type of prosthesis remains unclear and the presence of pulmonary arterial hypertension further complicates the management. We think that bioprosthetic valves would be the appropriate choice in eosinophilic mitral dysfunction requiring valve replacement. (J Card Surg 2009;24:80-82).
引用
收藏
页码:80 / 82
页数:18
相关论文
共 8 条
[1]
HYPEREOSINOPHILIC SYNDROME - CAUSE OF PROSTHETIC VALVE OBSTRUCTION [J].
ARSIWALA, S ;
PEEK, G ;
DAVIES, M ;
SOSNOSKI, A ;
FIRMIN, R .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (02) :545-546
[2]
Treatment with epoprostenol of pulmonary arterial hypertension following mitral valve replacement for mitral stenosis [J].
Elliott, CG ;
Palevsky, HI .
THORAX, 2004, 59 (06) :536-537
[3]
THE IDIOPATHIC HYPEREOSINOPHILIC SYNDROME - CLINICAL, PATHOPHYSIOLOGIC, AND THERAPEUTIC CONSIDERATIONS [J].
FAUCI, AS ;
HARLEY, JB ;
ROBERTS, WC ;
FERRANS, VJ ;
GRALNICK, HR ;
BJORNSON, BH .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (01) :78-92
[4]
The effect of inhaled nitric oxide and inhaled iloprost on hypoxaemia in a patient with pulmonary hypertension after pulmonary thrombarterectomy [J].
Flondor, M. ;
Merkel, M. ;
Hofstetter, C. ;
Irlbeck, M. ;
Frey, L. ;
Zwissler, B. .
ANAESTHESIA, 2006, 61 (12) :1200-1203
[5]
Fuzellier JF, 2004, J HEART VALVE DIS, V13, P529
[6]
Hii MW, 2006, J HEART VALVE DIS, V15, P721
[7]
Multiple valvar replacements for hypereosinophilic syndrome [J].
Radford, DJ ;
Garlick, RB ;
Pohlner, PG .
CARDIOLOGY IN THE YOUNG, 2002, 12 (01) :67-70
[8]
Watanabe K, 2002, J HEART VALVE DIS, V11, P447